2,884
Views
38
CrossRef citations to date
0
Altmetric
Original Articles

The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center

, , , , , , & show all
Pages 36-43 | Received 22 Dec 2017, Accepted 22 Sep 2018, Published online: 29 Nov 2018

References

  • Napoleone M, Kielar AZ, Hibbert R, et al. Local tumor progression patterns after radiofrequency ablation of colorectal cancer liver metastases. Diagn Interv Radiol. 2016;22:548–554.
  • Shibata T, Niinobu T, Ogata N, et al. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89:276–284.
  • Munireddy S, Katz S, Somasundar P, et al. Thermal tumor ablation therapy for colorectal cancer hepatic metastasis. J Gastrointest Oncol. 2012;3:69–77.
  • Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–766.
  • Cauchy F, Faivre S, Belghiti J. Surgical results after downstaging of initially marginal or non-resectable liver metastases. Dig Dis. 2012;30:143–149.
  • Liu Y, Li S, Wan X, et al. Efficacy and safety of thermal ablation in patients with liver metastases. Eur J Gastroenterol Hepatol. 2013;25:442–446.
  • Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the Interventional Oncology Sans Frontières meeting 2013. Eur Radiol. 2015;25:3438–3454.
  • Lee WS, Yun SH, Chun HK, et al. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol. 2008;42:945–949.
  • Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver. 2013;7:1–6.
  • Reuter NP, Woodall CE, Scoggins CR, et al. Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg. 2009;13:486–491.
  • Zorbas G, Samaras T. A study of the sink effect by blood vessels in radiofrequency ablation. Comput Biol Med. 2015;57:182–186.
  • Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166–175.
  • Tanis E, Nordlinger B, Mauer M, et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the european organisation for research and treatment of cancer #40004 and #40983. Eur J Cancer. 2014;50:912–919.
  • Boutros C, Somasundar P, Garrean S, et al. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol. 2010;19:e22–e32.
  • Rocha FG, D'Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102:968–974.
  • Gravante G, Ong SL, Metcalfe MS, et al. Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int. 2008;28:911–921.
  • Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19:1206–1213.
  • Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247.
  • Sun Y, Zhang G, Yu J, et al. Evaluation of percutaneous microwave coagulation therapy for hepatic artery injury. Heliyon. 2015;1:e30.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273:241–260.
  • Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386–1422.
  • Martin RC, Scoggins CR, Mcmasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010;17:171–178.
  • Lorentzen T, Skjoldbye BO, Nolsoe CP. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med. 2011;32:492–496.
  • Brace CL, Diaz TA, Hinshaw JL, et al. Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol. 2010;21:1280–1286.
  • Hammill CW, Billingsley KG, Cassera MA, et al. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol. 2011;18:1947–1954.
  • Nielsen K, van Tilborg AA, Meijerink MR, et al. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg. 2013;37:1340–1347.
  • van Tilborg AA, Scheffer HJ, de Jong MC, et al. MWA versus RFA for perivascular and peribiliary CRLM: a retrospective patient- and lesion-based analysis of two historical cohorts. Cardiovasc Intervent Radiol. 2016;39:1438–1446.
  • Hakime A, Tselikas L, Otmezguine Y, et al. Artificial ascites for pain relief during microwave ablation of subcapsular liver tumors. Cardiovasc Intervent Radiol. 2015;38:1557–1562.
  • Han Y, Yu L, Hao YZ, et al. Percutaneous radiofrequency ablation with artificial hydrothorax for liver cancer in the hepatic dome. Zhonghua Zhong Liu Za Zhi. 2012;34:846–849.
  • Yang B, Zou J, Xia J, et al. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation. Eur J Radiol. 2011;79:196–200.
  • Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158–171.
  • Kang TW, Lim HK, Lee MW, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology. 2016;280:300–312.
  • Francica G, Meloni MF, de Sio I, et al. Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy. Eur J Radiol. 2016;85:739–743.
  • Qin S, Chen Y, Liu XY, et al. Clinical application of contrast-enhanced ultrasound using high-frequency linear probe in the detection of small colorectal liver metastases. Ultrasound Med Biol. 2017;43:2765–2773.
  • Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23:2619–2626.
  • Stang A, Donati M, Weilert H, et al. Impact of systemic therapy and recurrence pattern on survival outcome after radiofrequency ablation for colorectal liver metastases. J Cancer. 2016;7:1939–1949.
  • Livraghi T, Meloni F, Solbiati L, et al. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012;35:868–874.
  • Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation-complications among cohort of 1136 patients. Radiology. 2009;251:933–940.